Search from website

Human IgG1-lambda antibody to SARS CoV-2 NP (clone 16C11)

 

Figure 1. Coomassie-stained SDS-PAGE analysis of monoclonal antibody to SARS-CoV-2 Nucleocapsid protein, clone 16C11. 4-12% gradient gel is used for analysis. Lane 1. Monoclonal antibody to SARS-CoV-2 Nucleocapsid protein, clone 16C11 (-DTT). Lane 2. Size marker. Lane 3. Monoclonal antibody to SARS-CoV-2 Nucleocapsid protein, clone 16C11 (+DTT).

       

Figure 2. HPLC analytical SEC for final product.

       

Figure 3. HPLC analytical SEC after 3 freeze-thaw cycles.

       

Figure 4. Octet RED96e analysis, antibody was loaded on sensor for capture of Nucleocapsid protein.

   

Select volume:

Quantity:

Catalogue #

R1-147-100

Name

Human IgG1-lambda antibody to SARS CoV-2 NP (clone 16C11)

Target

Nucleocapsid protein SARS-CoV-2

Target Description

Recombinant SARS-CoV-2 Nucleocapsid protein produced by CHO-based Icosagen Cell factory Ltd. proprietary suspension cell line

Clonality

Human monoclonal

Clone

16C11

Class

hIgG1

Reactivity

SARS-CoV-2 Nucleocapsid protein

Dissociation constant (KD)

8.8 x 10-10 M

Application

ELISA, WB

Kd:

8.8 x 10-10 M

ELISA:

0,08-0,16 µg/ml

WB:

0,5-1 µg/ml

Purification

Protein A affinity chromatography following desalting

Buffer

PBS pH 7.4

Shipping

Shipped at ambient temperature.

Storage

Store at +4 °C. Avoid multiple freeze-thaw cycles.

This product is for research use only

TECHNICAL ASSISTANCE

Please refer any technical questions to

technical.support@icosagen.com
Shopping Cart